ALNYLAM PHARMACEUTICALS INC's ticker is and the CUSIP is 02043Q957. A total of 3 filers reported holding ALNYLAM PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,956,000 | -70.8% | 500 | -68.8% | 0.36% | -80.8% |
| Q4 2017 | $20,366,000 | -45.2% | 1,603 | -49.4% | 1.86% | -23.7% |
| Q3 2017 | $37,186,000 | +95.0% | 3,165 | +32.4% | 2.43% | +94.7% |
| Q2 2017 | $19,071,000 | +50.2% | 2,391 | -3.5% | 1.25% | +82.2% |
| Q1 2017 | $12,695,000 | +64.9% | 2,477 | +20.5% | 0.68% | +52.9% |
| Q4 2016 | $7,698,000 | +30.7% | 2,056 | +136.6% | 0.45% | +102.7% |
| Q3 2016 | $5,890,000 | +75.1% | 869 | +43.4% | 0.22% | +26.3% |
| Q2 2016 | $3,363,000 | -47.0% | 606 | -23.2% | 0.18% | -33.0% |
| Q3 2015 | $6,340,000 | +33.9% | 789 | +99.7% | 0.26% | +50.9% |
| Q2 2015 | $4,735,000 | -21.6% | 395 | -48.9% | 0.17% | -25.4% |
| Q3 2014 | $6,037,000 | -11.2% | 773 | -28.2% | 0.23% | -20.3% |
| Q2 2014 | $6,797,000 | – | 1,076 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 84,300 | $15,917,000 | 0.02% |
| SIMPLEX TRADING, LLC | 33,600 | $5,703,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 36,000 | $6,797,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |